Hippocampal pathology in progressive supranuclear palsy (PSP): A quantitative study of 8 cases

Clinical Neuropathology

Volumn 28, Issue 1, 2009, Pages 46-53

  Armstrong, R A ^a   Lantos, P L ^b   Cairns, N J ^c  

^a ASTON UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glial inclusion (coiled body) (GI); Hippocampus; Neuritic plaque (NP); Neurofibrillary tangle (NFT); Progressive supranuclear palsy (PSP)

Indexed keywords

ADULT; AGED; ANTIBODY LABELING; ARTICLE; ASTROCYTE; CELL VACUOLE; CLINICAL ARTICLE; COGNITIVE DEFECT; COILED BODY; DENTATE GYRUS; FEMALE; GLIA CELL; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; NEUROFIBRILLARY TANGLE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; QUANTITATIVE ANALYSIS; SUBICULUM; TEMPORAL LOBE; TISSUE DISTRIBUTION; CELL INCLUSION; GLIA; MIDDLE AGED; PATHOLOGY; SENILE PLAQUE;

AGED; FEMALE; HIPPOCAMPUS; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEUROGLIA; NEURONS; SENILE PLAQUES; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 62849121767     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NPP28046     Document Type: Article

References (35)

1. Arima K, Nakamura M, Sunohara N, Nishio T, Ogawa M, Hirai S, Kawai M, Ikeda K. Immunohistochemical and ultrastructural characterization of neuritic clusters around ghost tangles in the hippocampal formation in progressive supranuclear palsy. Acta Neuropathol. 1999; 97: 565-576.
2. Armstrong RA. Is the clustering of neurofibrillary tangles in Alzheimer's patients related to the cells of origin of specific cortico-cortical projections? Neurosci Lett. 1993; 160: 57-60.
3. Armstrong RA. Correlations between the morphology of diffuse and primitive β-amyloid (Aβ) deposits and the frequency of associated cells in Down's syndrome. Neuropathol Appl Neurobiol. 1996; 22: 527-530.
4. Armstrong RA. Measuring the degree of spatial correlation between histological features in thin sections of brain tissue. Neuropathology. 2003; 23: 245-253.
5. Armstrong RA. Methods of studying the planar distribution of objects in histological sections of brain tissue. J Microsc. 2006; 221: 153-158.
6. Armstrong RA, Cairns NJ, Lantos PL. Clustering of Pick bodies in Pick's disease. Neurosci Lett. 1998; 242: 81-84.
7. Armstrong RA, Cairns NJ, Lantos PL. Clustering of cerebral cortical lesions in patients with corticobasal degeneration. Neurosci Lett. 1999; 268: 5-8.
8. Armstrong RA, Lantos PL, Cairns NJ. What does the study of spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disease? Neuropathology. 2001; 21: 1-12.
9. Armstrong RA, Lantos PL, Cairns NJ. Spatial patterns of the vacuolation in subcortical white matter in sporadic Creutzfeldt-Jakob disease (sCJD). Clin Neuropathol. 2002; 21: 284-288.
10. Armstrong RA, Cairns NJ, Lantos PL. A quantitative study of the pathological changes in white matter in multiple system atrophy. Neuropathology. 2007a; 27: 221-227.
11. Armstrong RA, Lantos PL, Cairns NJ. Progressive supranuclear palsy (PSP: a quantitative study of the pathological changes in cortical and subcortical regions of eight cases). J Neural Transm. 2007b; 114: 1569-1577.
12. Bigio EH, Brown DF, White CL. Progressive supranuclear palsy with dementia: cortical pathology. J Neuropathol Exp Neurol. 1999; 58: 359-364.
13. Bonelli RM, Cummings JL. Frontal-subcortical dementias. Neurologist. 2008; 14: 100-107.
14. Braak H, Jellinger K, Braak E, Bohl J. Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol. 1992; 84: 478-483.
15. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol. 1993; 33: 403-408.
16. Brion JP, Couck AM, Robertson J, Loviny TLF, Anderton BH. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-τ in Alzheimer's disease. J Neurochem. 1993; 60: 1372-1382.
17. Cairns NJ, Atkinson PF, Hanger D, Anderton BH, Daniel SE Lantos PL. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal τ in Alzheimer's disease. Neurosci Lett. 1997; 230: 49-52.
18. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord. 2003; 18: 784-790.
19. Cordata NJ, Duggins AJ, Halliday GM, Morris JGL, Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain. 2005; 128: 1259-1266.
20. De Lacoste M, White CL. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging. 1993; 14: 1-16.
21. Dickson DW. Neuropathological differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999; 246: 6-15.
22. Hattori M, Hashizume Y, Yoshida M, Iwasaki Y, Hishikawa N, Ueda R, Ojika K. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol. 2003; 108: 143-149.
23. Hiorns RW, Neal JW, Pearson RCA, Powell TPS. Clustering of ipsilateral cortico-cortical projection neurons to area 7 in the rhesus monkey. Proc Roy Soc Lond. 1991; 246: 1-9.
24. Hof PR, Delacourte A, Bouras C. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol. 1992; 84: 45-51.
25. Komori T. τ-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol. 1999; 9: 663-679.
26. Lantos PL. The neuropathology of progressive supranuclear palsy. J Neural Transm (Suppl). 1994; 42: 137-152.
27. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Davoisen RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS, Chase TN, Fitzgibbon EJ, Hall Z, Juncos J, Nelson KB, Oliver E, Pramstaller R, Verny M. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996a; 47: 1-9.
28. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW. Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996b; 55: 97-105.
29. Matsusaka H, Ikeda K, Akiyama H, Arai T, Inoeu M, Yagishita S. Astrocyte pathology in progressive supranuclear palsy: significance for neuropathological diagnosis. Acta Neuropathol. 1998; 96: 248-252.
30. Mattila P, Togo T, Dickson DW. The subthalamic nucleus has neurofibrillary tangles in argyrophilic grain disease and advance Alzheimer's disease. Neurosci Lett. 2002; 320: 81-85.
31. Mckenzie IRA, Hudson LP. Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol. 1995; 90: 615-619.
32. Schrag A. Structural imaging in the differential diagnosis of parkinsonian syndromes. Nervenheilkunde. 2000; 19: 479-481.
33. Shinotoh H, Namba H, Yamaguchi M, Fukushi K, Nagatsuka S, Iyo M, Asahina M, Hattori T, Tanada S, Irie T. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Ann Neurol. 1999; 46: 62-69.
34. Verny M, Duyckaerts C, Agid Y, Hauw JJ. The significance of cortical pathology in progressive supranuclear palsy: clinicopathological data in 10 cases. Brain. 1996; 119: 1123-1136.
35. Williams DR, Holton JL, Strand C, Pittman A, de Silva R, Lees AJ, Revesz T. Pathological τ burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain. 2007; 130: 1566-1576.